Tried to do my part over there with the following

New Post Public Reply Private Reply Replies (1) Message Board
petemantx scgmck1 #66460
594
Tried to do my part over there with the following post:

The less IPIX gains today the more it proves that IPIX has the big boys scared to death.

Does anyone believe news of this positive caliber from a small startup would cause such a runup in volume but no price gain if it was just a bit player? Of course not.

Our lack of share price appreciation shows IMO that either a BP, or BPs, a possible hedge fund or multiple hedge funds, day trader groups, etc are worried ****less over IPIX succeeding and throwing their aims in the dumpster.

Does it really matter what today's ending price is other than a feel good?

Who other than the core group that has been following IPIX for months to years saw this PR? IMO, very few.

So why the volume? Could just be trading groups such as Cl** Trader doing their pump and dump price action. We know it certainly isn't any longs selling.

IPX with Brilacidin and Kevetrin could upset the largest horse cart in America (as shown by the amount paid by lobbyists to further their cause)- that of the Big Pharmas. Brilacidin alone may undo the cash cow revenues of MANY currently large drugs these BPs rely on for their income.

Until we see the government/major media extol the greatness of Brilacidin, until the peer review article is published and we get extremely positive feedback from top medical doctors/scientists, and until we get some large funds thru whatever means our share price remains in the hands of those wanting it to remain low.

About time posters quit asking every day about the share price, whining that it isn't going up like they want, questioning if things really are going on behind the scenes (I actually take many of these folks to be snakes in the grass or just plain stupid newbies).

We have the golden egg layer in Brilacidin IMO and not far behind is Kevetrin which just needs to get into pill form to start strutting its stuff.

There is a season..... goes a popular song. Our season has started and the rewards are quickly coming as well (most likely prior to the end of the year) so lets settle down and bask in the PRs good news instead of wailing about the stock price.

I bought another nice chunk (at least for me) today as each PR lowers the risk IMO and currently it is just about as hard to find as is CV19 after being hit with a shot of Brilacidin.

It was removed within minutes by jackhole SS so I have requested a review. If this post isn't on topic, what is?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Latino Real Estate Agents Lead Growth Amid Market Challenges

Updated Category News Views 289

NAHREP’s Top 250 Latino Agents Report Highlights Industry Trends The National Association of Hispanic Real Estate Professionals (NAHREP) recently published its annual Top 250 Latino Agents Report, showcasing the incredible achievements of 778 exceptional Latino real estate agents across the country. Despite the real estate market facing considerable struggles, these top...

Continue Reading
Exploring the Expanding Landscape of Satellite Internet Services

Updated Category News Views 241

Revolutionizing Connectivity: The Satellite Internet Industry "The global satellite internet market is expanding as satellites provide high-speed internet access to even the most remote areas." The satellite internet market has seen tremendous growth recently, highlighting the need for high-speed connectivity in every corner of the globe. As the landscape evolves,...

Continue Reading
Interfor's Strategic Lumber Production Adjustments Ahead

Updated Category News Views 221

Interfor Adjusts Lumber Production for Market Conditions In a recent announcement, Interfor Corporation (TSX: IFP), a leading player in the forest products industry, shared its plans to modify lumber production strategies for the upcoming quarter. The adjustments come amid continuing challenges in market demand and economic fluctuations affecting the timber sector....

Continue Reading
Sage Therapeutics to Share Q3 2024 Financial Insights Soon

Updated Category News Views 87

Sage Therapeutics Plans Upcoming Financial Webcast Sage Therapeutics, Inc. (NASDAQ: SAGE) is gearing up for a significant event by announcing that it will host a live webcast to discuss its financial performance for the third quarter of 2024. Scheduled for a future date, this presentation aims to give insights into the company's financial results and convey important...

Continue Reading
Covenant Health Data Breach: What Affected Customers Need to Know

Updated Category News Views 114

Covenant Health Data Breach Investigation Recent developments have emerged concerning a significant data breach at Covenant Health, Inc. This incident has caught the attention of many, especially those affected by the breach. The investigation into these claims is led by the dedicated law firm Edelson Lechtzin LLP. They are focused on addressing the privacy concerns of...

Continue Reading